Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000827871-15-000007
Filing Date
2015-01-28
Accepted
2015-01-28 11:45:05
Documents
4
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-K/A a10-ka.htm 10-K/A 332033
2 EXHIBIT 31.1 exhibit31110-ka.htm EX-31.1 10764
3 EXHIBIT 31.2 exhibit31210-ka.htm EX-31.2 10707
4 EXHIBIT 32.1 exhibit32110-ka.htm EX-32.1 4751
  Complete submission text file 0000827871-15-000007.txt   359367
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36306 | Film No.: 15553739
SIC: 2834 Pharmaceutical Preparations